Skip to main content

Scheduled maintenance

Location search will not be available from Sunday, April 12 at 9:00 PM EDT until Sunday, April 12 at 11:00 PM EDT due to planned site maintenance. We apologize for any inconvenience.

Hide
Quest Diagnostics

Customization of the ACMG/AMP Framework for Rett and Angelman-like Disorders Presents Unique Challenges

CGC 2021: Curating the Clinical Genome
Virtual [in-person conference canceled], May 12-14, 2021

Customization of the ACMG/AMP Framework for Rett and Angelman-like Disorders Presents Unique Challenges
Authors: McKnight D, Bean L, Karbassi I, Beattie k, Bienvenu T, Bonin H, Cheng H, Chrisodoulou J, Fang P, Friez M, Helgeson M, Krishnaraj R, Meng L, Mighion L, Murphy K, Neul J, Percy A, Ramsden S, Zoghbi H, Das S

Specialties: Genetics, Neurology

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.